首页> 外文期刊>Infection and immunity >Induction of Protective Cellular Immunity against Mycobacterium tuberculosis by Recombinant Attenuated Self-Destructing Listeria monocytogenes Strains Harboring Eukaryotic Expression Plasmids for Antigen 85 Complex and MPB/MPT51
【24h】

Induction of Protective Cellular Immunity against Mycobacterium tuberculosis by Recombinant Attenuated Self-Destructing Listeria monocytogenes Strains Harboring Eukaryotic Expression Plasmids for Antigen 85 Complex and MPB/MPT51

机译:携带抗原85复合物和MPB / MPT51真核表达质粒的重组减毒自毁性单核细胞增生李斯特菌菌株诱导的针对结核分枝杆菌的保护性细胞免疫

获取原文
       

摘要

We report here the induction of specific protective cellular immunity against Mycobacterium tuberculosis by the employment of vaccination with recombinant attenuated Listeria monocytogenes strains. We constructed self-destructing attenuated L. monocytogenes Δ2 strains carrying eukaryotic expression plasmids for the antigen 85 complex (Ag85A and Ag85B) and for MPB/MPT51 (mycobacterial protein secreted by M. bovis BCG/mycobacterial protein secreted by M. tuberculosis) molecules. Infection of these recombinant bacteria allowed expression of the genes in the J774A.1 murine macrophage cell line. Intraperitoneal vaccination of C57BL/6 mice with these recombinant bacteria was capable of inducing purified protein derivative-specific cellular immune responses, such as foot pad reactions, proliferative responses of splenocytes, and gamma interferon production from splenocytes, suggesting the efficacy of vaccination against mycobacterial infection by use of these recombinant L. monocytogenes strains. Furthermore, intravenous vaccination with recombinant bacteria carrying expression plasmids for Ag85A, Ag85B, or MPB/MPT51 in BALB/c mice elicited significant protective responses, comparable to those evoked by a live Mycobacterium bovis BCG vaccine. Notably, this is the first report to show that MPB/MPT51 is a major protective antigen in addition to Ag85A and Ag85B, which have been reported to be major mycobacterial protective antigens.
机译:我们在这里报告了通过使用重组减毒的单核细胞增生李斯特菌菌株的疫苗接种诱导的针对结核分枝杆菌的特异性保护性细胞免疫。我们构建了自毁衰减的 L。携带真核表达质粒的单核细胞增生Δ2菌株,分别用于抗原85复合物(Ag85A和Ag85B)和MPB / MPT51(牛分枝杆菌分泌的分枝杆菌蛋白BCG / 分泌的分枝杆菌蛋白)结核分枝杆菌)分子。这些重组细菌的感染使基因在J774A.1鼠巨噬细胞系中表达。用这些重组细菌对C57BL / 6小鼠进行腹膜内疫苗接种能够诱导纯化的蛋白衍生物特异性细胞免疫反应,例如脚垫反应,脾细胞的增殖反应以及脾细胞产生的γ干扰素,提示疫苗接种对分枝杆菌感染的功效通过使用这些重组的 L。单核细胞增生菌菌株。此外,与带有活牛分枝杆菌BCG疫苗的疫苗相比,BALB / c小鼠中携带带有Ag85A,Ag85B或MPB / MPT51表达质粒的重组细菌的静脉接种可引起显着的保护反应。值得注意的是,这是第一份表明MPB / MPT51是除Ag85A和Ag85B之外的主要保护性抗原,Ag85A和Ag85B被报道是主要的分枝杆菌保护性抗原。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号